期刊文献+

超选择子宫动脉与外周静脉灌注化疗宫颈癌组织内铂浓度的研究 被引量:5

A Comparative Study of the Difference of Infusion Chemotherapies Through Ultraselected Uterine Artery or Peripheral Vein on the Intratumoral Platinum Concentration in the Carcinoma of the Cervix
下载PDF
导出
摘要 目的:对比卡铂超选择子宫动脉与外周静脉灌注化疗子宫颈癌组织内的药物浓度。方法:选择经病理活组织证实为宫颈癌、且癌灶较大易于取材的患者13例,随机分为超选择子宫动脉灌注化疗组(A组)和外周静脉灌注化疗组(B组),以卡铂300mg/m2,一次性给药。在灌注后0min、10min、20min分别钳取宫颈癌组织,用原子吸收光谱法测定其标本内铂离子浓度。结果:(1)峰值及曲线形态:A组癌组织铂离子浓度的高峰值出现在化疗结束后即刻,且随时间的延长而快速下降,呈一下降曲线;B组峰值出现在化疗后10分钟,随时间的延长呈一弓背向上的下降曲线。前者的峰值是后者的2.79倍,差异有统计学意义(P<0.05)。(2)灌注化疗结束后即刻,A组宫颈癌组织内铂离子浓度是B组的3.75倍,差异有统计学意义(P<0.05)。(3)A组癌组织内铂离子药时曲线下面积(AUC0~20min)是B组的2.10倍,差异有显著意义(P<0.05)。结论:无论癌组织内铂离子峰浓度还是AUC0~20min,超选择子宫动脉灌注化疗组均较外周静脉组明显增高,为评价动脉化疗疗效提供了基础理论依据及临床药代动力学参数。 Objective: To compare the intratumoral platinum concentrations of infusion chemotherapies with carboplatin through ultraselected uterine artery or peripheral vein for the carcinoma of the cervix. Methods: 13 patients with local advanced cervical cancer who had been confirmed by pathobiopsy were enrolled in the study. 13 patients were randomly divided into two groups. Group A with 6 patients were treated using intra-uterine artery carboplatin 300mg/m^2 , and group B with 7 patients using intra-vein carboplatin 300mg/m^2. The tumors were biopsied at 0,10 and 20 minutes after completion of the infusion. The platinum concentrations of samples were detected by flameless atomic absorption spectrophotometer. Results: ( 1 ) The peak values of platinum concentration in tissues were existed at 0 minute after inter-arterial infusion of carboplatin in the group A, and at 10 minute in the group B. The peak values of platinum concentration in tissues of the group A were 2.79 times higher than that of the group B, and there was significantly difference( P 〈 0.05 ). The platinum concentration in the cancer tissues decreased with time in the group A, and the pattern of first decline followed by rising curve with time was demonstrated in the group B. (2) At 0 minute after infusion chemotherapy, intratumor platinum concentrations of the group A were 3.75 times higher than that of the group B( P 〈 0. 05 ), and there was significantly difference. (3) AUC 0-20min of the group A was 2.10 times higher than that of the group B. The difference had statistical significance (P 〈 0.05). Conclusion: Both for the peak value of platinum concentration in tissues and the area under the tissue concentration-time curve, the group A were significantly higher than those of the group B, which provides theoretical basis and laboratory parameter for evaluating the effect of the intra-arterial infusion chemotherapy.
出处 《肿瘤预防与治疗》 2008年第4期390-393,共4页 Journal of Cancer Control And Treatment
关键词 子宫颈癌 子宫动脉 静脉 灌注化疗 铂离子峰浓度 药时曲线下面积 Cervical Cancer Uterine Artery Vein Intra-Arterial Infusion Chemotherapy Peak Value of Platinum Area Under the Concentration Time Curve
  • 相关文献

参考文献13

  • 1[1]Minagawa Y,Kigawa J,Irie T,et al.Radical surgery following neoadjuvant chemotherapy for patients with stage ⅢB cervica cancer[J].Ann Surg Oncol,1998,5:539-543.
  • 2[2]Horn LC,FischerU,Bilek K.Histopathological pmgnostic factors in primary surgically treated cervix carcinoma[J].Zentralbl Gynakol,2001,123(5):266-274.
  • 3[3]Scheungraber C,MullerB,Kohler C,et al.Detection of disseminated tumor cells in patients with cervical cancer[J].J Cancer Res Clin Oncol,2002,128(6):329-335.
  • 4[4]Frei E 3 rd.Clinical cancer research:an embattled species[J].Cancer,1982,50:1979-1992.
  • 5[5]Neoadjuvant Chemotherapy for locally Advanced Cervical Cancer Meta2analysis Collaboration.Necadjuvant chemotherapy for local2 ly advanced cervical cancer:a systematic review and meta2analysis of individual patient data from 21 randomized trilas[J].Eur J Cancer,2003,39(17):2470-2486.
  • 6赵文娟.新辅助化疗在宫颈癌术前治疗中的应用[J].职业与健康,2007,23(9):761-762. 被引量:4
  • 7马秋英.宫颈癌手术前治疗[J].华夏医学,2007,20(5):1145-1148. 被引量:6
  • 8刘月红.新辅助化疗在宫颈癌术前治疗中的评价[J].医学临床研究,2006,23(3):380-382. 被引量:4
  • 9庞义存,宋月卿.巨块型宫颈癌介入化疗疗效探讨[J].介入放射学杂志,2004,13(6):530-531. 被引量:24
  • 10[10]Tabata T,Takeshima N,Nishida H,et al.Arandomized study of primary bleomyein,vincristine,mitomycinandcisplat (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage ⅢB and IVA squamous cell carcinoma of the cervix[J].Anticancer Res,2003,23:2885-2890.

二级参考文献53

共引文献298

同被引文献38

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1477
  • 2王平,彭芝兰,张家文,刘辉,张崇淑,曹泽毅.子宫颈癌新辅助化疗中不同化疗途径的疗效比较[J].中华妇产科杂志,2005,40(4):227-230. 被引量:109
  • 3王艳,佐满珍,曹野.介入化疗栓塞加手术治疗晚期宫颈癌的疗效分析[J].中国美容医学(综合),2011,1(2):291.
  • 4赫捷,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:12-25.
  • 5Spitzer WO, Dobson A J, Hall J, et al. Measuring the quality of life of cancer patients a concise QL-index for use by physi- cians[ J]. J Chronic Dis,1981,34(12) :585-597.
  • 6Kim HS, Sardi JE, Katsumata N, et al. Efficacy of neoadju- vant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer:an international collaborative meta-analysis [J]. Eur J Surg Oncol,2012,39(2) :115 - 124.
  • 7Strecker EP, Heber R, Boos I, et al. Preliminary experi- ence with locoregional intraarterial chemotherapy of uter- ine cervical or endometrial cancer using the peripheral implantable port system (PIPS) : a feasibility study [ J ]. Cardiovasc Intervent Radiol,2003,26(2) :118-122.
  • 8Motoyama S, Humana S, Ku Y, et al. Neoadjuvant high- dose intraarterial infusion chemotherapy under percutane- ous pelvic perfusion with extracorporeal chemofihration in patients withstages llIa : IV a cervical cancer [ J ]. Gyne- col Onco1,2012,95 (3) : 576-582.
  • 9美国东部肿瘤协作组.抗癌药急性及亚急性毒性反应分度标准(WHO标准)[J].癌症,1992,7(3):280.
  • 10Zanaboni F, Grijuela B, Giudici S, et al. Weekly topotecan and cisplatin(TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma:Results of a phase II multicentric study [ J]. Eur J Cancer, 2013,49 (5):1 065-1 066.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部